Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Full Text
This week's Diabetes Bulletin...
...
A current awareness service produced by the Health Sciences Library of East Cheshire NHS Trust.
|
|||
|
No comments:
Post a Comment